Carl Zimmer is presenting a series of posts by Ken Miller in which Miller takes on DI-flack Casey Luskin's attempt to claim that he misrepresented research regarding the evolution of clotting proteins when he gave testimony in Kitzmiller v. Dover (way back in 2005).
See here and here. The third - and final - part will appear tomorrow apparently.
More like this
From here:
Late last week saw two announcements from the US FDA on genetic issues in drug safety. The first of these addresses the prescribing guidelines for Coumadin, or warfarin.